Characterizing ERBB2 Mutations in Non-Small Cell Lung Carcinoma: University Health Network Experience

被引：0

作者：

Chang, Nina ^{[1
]}

Perdrizet, Kirstin ^{[1
]}

Stockley, Tracy ^{[2
]}

Tsao, Ming ^{[3
]}

Shepherd, Frances ^{[1
]}

Wei, Cuihong ^{[1
]}

Ranich, Laura ^{[1
]}

Liu, Geoffrey ^{[1
]}

Sacher, Adrian ^{[1
]}

Bradbury, Penelope ^{[4
]}

Hwang, David ^{[5
]}

Schwock, Joerg ^{[1
]}

Ko, Hyang Mi ^{[1
]}

Boerner, Scott ^{[6
]}

Law, Jennifer ^{[4
]}

Leighl, Natasha ^{[1
]}

Pal, Prodipto ^{[7
]}

机构：

[1] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada

[2] Univ Hlth Network, Genome Diagnost, Toronto, ON, Canada

[3] Univ Hlth Network, Toronto, ON, Canada

[4] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada

[5] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

[6] Univ Toronto, Univ Hlth Network, Mississauga, ON, Canada

[7] Univ Hlth Network, Scarborough, ON, Canada

来源：

LABORATORY INVESTIGATION | 2019年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1814

引用

页数：1

共 50 条

[21] Clinicopathologic and molecular characteristics in ERBB2 (HER2)-altered non-small cell lung cancer
Lee, Y.
Lee, B.
Choi, Y.
VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S151 - S152
[22] Stereotactic Body Radiotherapy for Non-small Cell Lung Carcinoma: The Indiana University Experience
Fakiris, A. J.
Forquer, J.
Henderson, M.
Barriger, R.
Shapiro, R.
Brabham, J.
Johnstone, P.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S167 - S167
[23] Activating ERBB4 mutations in non-small cell lung cancer
Kurppa, Kari J.
Denessiouk, Konstantin
Johnson, Mark S.
Elenius, Klaus
CANCER RESEARCH, 2015, 75
[24] Activating ERBB4 mutations in non-small cell lung cancer
K J Kurppa
K Denessiouk
M S Johnson
K Elenius
Oncogene, 2016, 35 : 1283 - 1291
[25] Activating ERBB4 mutations in non-small cell lung cancer
Kurppa, K. J.
Denessiouk, K.
Johnson, M. S.
Elenius, K.
ONCOGENE, 2016, 35 (10) : 1283 - 1291
[26] The Spectrum of EGFR Mutations in Non-Small Cell Carcinoma of Lung
Evans, M.
O'Sullivan, B.
Hughes, F.
Swift, C.
Mullis, T.
Dessi, R.
Smith, M.
Taniere, P.
JOURNAL OF PATHOLOGY, 2016, 238 : S17 - S17
[27] A case series of ERBB2 indel driver mutations in non-small cell lung cancer identified by cell-free circulating tumor DNA NGS
Peled, Nir
Belilovski-Rozenblum, Anna
Soussan-Gutman, Lior
Lee, Christine
Talasaz, AmirAli
Lanman, Richard B.
CANCER RESEARCH, 2016, 76
[28] Clinicopathological Features of Insertion Mutations in Kinase Domain of EGFR and ERBB2 in Non-Small-Cell Lung Cancer
Zhao, Ruiying
Xiang, Chan
Zhu, Lei
Shao, Jinchen
Zhao, Jikai
Guo, Lianying
Ma, Shengji
Yu, Anbo
Han, Yuchen
LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1833 - 1834
[29] Clinicopathological Features of Insertion Mutations in Kinase Domain of EGFR and ERBB2 in Non-Small-Cell Lung Cancer
Zhao, Ruiying
Xiang, Chan
Zhu, Lei
Shao, Jinchen
Zhao, Jikai
Guo, Lianying
Ma, Shengji
Yu, Anbo
Han, Yuchen
MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1833 - 1834
[30] Autocrine activation of ErbB2/ErbB3 receptor complex by NRG-1 in non-small cell lung cancer cell lines
Gollamudi, M
Nethery, D
Liu, JB
Kern, JA
LUNG CANCER, 2004, 43 (02) : 135 - 143

← 1 2 3 4 5 →